Heme-regulated inhibitor kinase (HRI)

Heme-regulated inhibitor kinase (HRI), encoded by the EIF2AK1 gene, is a member of the eIF2α kinase family and a central mediator of the integrated stress response (ISR). It was originally identified in reticulocytes as a sensor that couples globin protein synthesis to heme availability, ensuring that hemoglobin components are produced in balanced proportions (UniProt P33261). Under conditions of heme deficiency, mitochondrial stress, or proteotoxic insult, HRI undergoes autophosphorylation and subsequently phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF2α) at Ser51. This action inhibits global protein synthesis while paradoxically promoting the translation of specific mRNAs, such as ATF4, which orchestrate a gene expression program aimed at cellular recovery or apoptosis (NIH/PubMed 32649884). In oncology, pharmacologic activation of HRI is being investigated as a strategy to trigger apoptosis in proteasome-inhibitor-resistant cancers like multiple myeloma (NIH/PubMed 33028637). In hematology, HRI inhibition is a promising approach for treating sickle cell disease and beta-thalassemia, as it has been shown to repress BCL11A and induce the production of fetal hemoglobin (ASH Publications 2024/11/05). Additionally, HRI's role in mitochondrial-to-nuclear signaling via the DELE1 protein suggests potential therapeutic utility in neurodegenerative and mitochondrial diseases (eLife 2024/09/25).

Other names

EIF2AK1Heme-controlled repressorHCRHeme-regulated eIF2-alpha kinaseHeme-sensitive initiation factor 2-alpha kinase

HRI-targeted therapies act by modulating the kinase's ability to phosphorylate the alpha subunit of eukaryotic initiation factor 2 (eIF2α). Activators (e.g., BTdCPU, PG3) stimulate HRI to induce a sustained integrated stress response (ISR), leading to translation arrest and apoptosis in cancer cells. Inhibitors (e.g., Dabrafenib, Encorafenib, and novel small molecules) prevent eIF2α phosphorylation, which can restore protein synthesis in stressed cells or modulate gene expression, such as inducing fetal hemoglobin in erythroid precursors by repressing BCL11A.